<DOC>
	<DOCNO>NCT01589562</DOCNO>
	<brief_summary>The purpose study evaluate pharmacokinetics Daewon DW-ES ( B ) 625mg/5ml Megace 800mg/20ml healthy male volunteer feed condition .</brief_summary>
	<brief_title>Phase 1 Study Daewon-ES ( B ) &amp; Megace Healthy Male Volunteers Under Fed Condition</brief_title>
	<detailed_description />
	<mesh_term>Megestrol</mesh_term>
	<mesh_term>Megestrol Acetate</mesh_term>
	<criteria>Adult male age 20 40 year screen . No significant congenital/chronic disease . No symptoms physical examination . Appropriate subject determine past medical history , laboratory test , serology urinalysis . Be able understand objective , method study , characteristic investigational drug , comply requirement study . Subject must provide write informed consent prior study participation History presence liver , kidney , nervous system disease , respiratory disorder , endocrinological disorder , hematooncologic , cardiovascular psychiatric cognitive disorder . History gastrointestinal disorder ( bleed , ulceration , hemorrhoid , pile ) disorder absorption , distribution , metabolism , excretion . History take megestrol</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>January 2013</verification_date>
</DOC>